Delivery Order SPE2DB20D3103-SPE2DB25FM1G4

Award Date 12/26/24
Potential Completion Date 12/27/24
Potential Value $77K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM1G4
    Delivery Order

This federal contract award, valued at $77,261.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026.

The contract covers the delivery of RINVOQ ER 15 MG TABLET, a pharmaceutical product, to support military healthcare programs. No set-aside designation was used for this award. Amerisourcebergen's extensive supply chain and distribution capabilities, as well as its significant presence as a vendor for federal healthcare programs, particularly within the DLA and Department of Justice, make it a key supplier of pharmaceutical and medical products to the U.S. government.

Generated 3/27/25, 9:42 AM